Covista Inc. SEC filings document the company’s transition from Adtalem Global Education Inc. and its ongoing disclosures as a healthcare education company. Recent 8-K filings cover certificate and bylaw amendments for the name change, the related ticker change from ATGE to CVSA, academic and financial results, enrollment trends, guidance updates, and Regulation FD investor materials.
The filings also describe capital-structure and governance matters, including credit agreement amendments, term loan refinancing, senior secured notes redemption, share repurchase authorizations, and annual meeting vote results. These records frame the company’s public-company reporting around healthcare education operations, institutional performance, capital allocation, debt arrangements, and shareholder governance.
Adtalem Global Education (ATGE) reported a routine insider transaction on a Form 4. The Chairman & CEO executed a Code F transaction, withholding 9,204 shares of common stock at $96.26 to satisfy taxes upon the vesting of previously awarded RSUs on 11/13/2025.
Following this tax withholding, the officer now beneficially owns 450,530 shares, held directly. The filing notes the activity was tied to RSU vesting and reflects non-open-market share withholding to cover tax obligations.
Adtalem Global Education (ATGE) reported an insider transaction by its Chief Financial Officer. On 11/10/2025, the CFO had 1,637 shares of common stock withheld to satisfy tax obligations upon the vesting of previously awarded restricted stock units, coded F, at a price of $95.19 per share.
Following this tax withholding, the officer beneficially owns 62,170 shares of Adtalem common stock, held directly. The filing notes the shares were withheld specifically to cover taxes related to RSU vesting.
Adtalem Global Education (ATGE) reported a routine insider trade by a director. On November 5, 2025, the director purchased 508 shares of common stock at a price of $98.29 per share. Following the transaction, the director directly owned 18,783 shares. The filing was made by a single reporting person.
Adtalem Global Education (ATGE) reported an insider purchase. The company’s Lead Independent Director, a member of the board, purchased 1,000 shares of common stock at $91.85 on 11/04/2025. Following this transaction, the insider beneficially owns 100,445 shares, held directly.
Adtalem Global Education (ATGE) reported first-quarter fiscal 2026 results for the period ended September 30, 2025. Revenue rose to $462.3 million from $417.4 million, driven by Chamberlain $179.2 million, Walden $190.0 million, and Medical & Veterinary $93.1 million. Operating income increased to $85.5 million and net income to $61.8 million, with diluted EPS of $1.67 versus $1.18 a year ago.
Cash from operations was strong at $130.6 million, lifting cash and equivalents to $264.7 million. Interest expense declined to $11.1 million. The company repurchased 56,817 shares for $7.6 million in the quarter; $142.4 million remains authorized. Deferred revenue rose to $322.9 million, reflecting student billing cycles and material rights.
Adtalem ended the quarter with long-term debt principal of $558.3 million (Notes $405.0 million, Term Loan B $153.3 million) and subsequently prepaid $50.0 million on October 29, 2025. The revolving credit facility was expanded to $500.0 million and extended to August 6, 2030, with full availability at quarter-end. The effective tax rate was 20.6%. Contingencies include borrower defense applications received by several institutions; outcomes and any recoupment decisions would follow separate processes.
Adtalem Global Education Inc. (ATGE) furnished an 8‑K announcing that it issued a press release with its first quarter fiscal 2026 academic, operating, and financial results. The press release is attached as Exhibit 99.1 and incorporated by reference.
The company states this information is provided under Item 2.02 and is furnished, not filed under the Exchange Act. The filing includes a customary caution about forward‑looking statements referencing risk factors in its most recent 10‑K.
Adtalem Global Education (ATGE) reported an insider transaction by its CHRO. On 10/15/2025, 1,310 shares of common stock were withheld at $148.62 per share (code F) to satisfy tax obligations upon the vesting of previously awarded restricted stock units.
Following this tax withholding, the reporting person beneficially owns 8,603 shares, held directly.
Dimensional Fund Advisors LP filed an amended Schedule 13G reporting beneficial ownership of 1,854,006 shares of Adtalem Global Education Inc. Common Stock, representing 5.2% of the class as of 09/30/2025. Dimensional states these shares are held on behalf of registered investment companies, commingled funds, group trusts and separate accounts (the "Funds") and disclaims beneficial ownership; all reported shares are owned by the Funds.
The filing shows 1,802,111 shares with sole voting power and 1,854,006 shares with sole dispositive power. Dimensional certifies the securities are held in the ordinary course of business and not for the purpose of influencing control. The filing is signed by the Global Chief Compliance Officer on 10/09/2025.
Adtalem Global Education, Inc. reported a leadership change at Chamberlain University following the retirement of Dr. Cox after a distinguished, nearly 40-year career in healthcare and nursing education. Dr. Cox led Chamberlain since 2018, during which the institution expanded to serve nearly 40,000 students online and across 24 physical campuses and became the largest school of nursing in the U.S. and the leading grantor of Bachelor of Science in Nursing degrees. The filing frames this as a material event related to leadership transition; financial results, transactions, and other operational details were not disclosed in the provided excerpt.
Stephen W. Beard, Chairman & CEO of Adtalem Global Education Inc. (ATGE), reported a sale of common stock on 09/08/2025. The Form 4 shows 12,943 shares were disposed of at $136.28 per share, leaving Mr. Beard with 459,734 shares beneficially owned on a direct basis. The filing states the sale represented the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. The form was signed by an attorney-in-fact on 09/09/2025.